R.H. Bluestein & Co’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-4,265
| Closed | -$380K | – | 343 |
|
|
2018
Q1 | $380K | Sell |
4,265
-425
| -9% | -$37.9K | 0.02% | 201 |
|
|
2017
Q4 | $489K | Sell |
4,690
-80,768
| -95% | -$8.42M | 0.03% | 149 |
|
|
2017
Q3 | $12.5M | Buy |
85,458
+82,458
| +2,749% | +$12M | 0.68% | 41 |
|
|
2017
Q2 | $390K | Hold |
3,000
| – | – | 0.02% | 173 |
|
|
2017
Q1 | $373K | Sell |
3,000
-6,300
| -68% | -$783K | 0.02% | 191 |
|
|
2016
Q4 | $1.08M | Buy |
9,300
+6,200
| +200% | +$717K | 0.07% | 66 |
|
|
2016
Q3 | $324K | Buy |
3,100
+100
| +3% | +$10.5K | 0.02% | 185 |
|
|
2016
Q2 | $296K | Hold |
3,000
| – | – | 0.02% | 183 |
|
|
2016
Q1 | $300K | Sell |
3,000
-1,675
| -36% | -$168K | 0.02% | 195 |
|
|
2015
Q4 | $560K | Sell |
4,675
-1,000
| -18% | -$120K | 0.04% | 119 |
|
|
2015
Q3 | $614K | Sell |
5,675
-250
| -4% | -$27K | 0.04% | 111 |
|
|
2015
Q2 | $686K | Buy |
5,925
+178
| +3% | +$20.6K | 0.04% | 131 |
|
|
2015
Q1 | $663K | Buy |
5,747
+897
| +18% | +$103K | 0.04% | 129 |
|
|
2014
Q4 | $543K | Sell |
4,850
-2,200
| -31% | -$246K | 0.03% | 172 |
|
|
2014
Q3 | $668K | Sell |
7,050
-3,900
| -36% | -$370K | 0.04% | 155 |
|
|
2014
Q2 | $940K | Buy |
10,950
+6,100
| +126% | +$524K | 0.06% | 121 |
|
|
2014
Q1 | $339K | Sell |
4,850
-1,150
| -19% | -$80.4K | 0.02% | 250 |
|
|
2013
Q4 | $507K | Sell |
6,000
-32,580
| -84% | -$2.75M | 0.03% | 192 |
|
|
2013
Q3 | $2.97M | Buy |
38,580
+32,580
| +543% | +$2.51M | 0.21% | 59 |
|
|
2013
Q2 | $351K | Buy |
+6,000
| New | +$351K | 0.03% | 214 |
|